Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

The first patients have been dosed in a multi-regional Phase IIB randomized, placebo-controlled clinical trial for the treatment of hepatitis B-associated liver cancer.